A Landmark UK-US Pharmaceutical Trade Deal: What It Means for Life Sciences and Patients

Life Science

A Landmark UK-US Pharmaceutical Trade Deal: What It Means for Life Sciences and Patients

An OVID Health article by Ollie George Yesterday the UK Government announced a landmark UK-US pharmaceutical trade deal designed to safeguard medicines access and reinforce the UK’s position as a life sciences superpower. The deal delivers headline commitments that have been widely welcomed by industry: ·      Zero tariffs on pharmaceutical exports ·      A reduced VPAG

Labour’s Life Sciences Strategy – more of the same?

a small collection of pills

Whilst the date of the General Election is yet to be announced, both the Conservative and Labour Parties have started 2024 in full campaign mode. Long accused of having no real policies, the latest offering from Labour – a Life Sciences Sector Strategy announced today at an industry roundtable at the Stevenage Bioscience Catalyst –

Contact.

OVID Health
1 Lyric Square
London, England
W6 0NB

+44 (0) 330 111 0255
[email protected]

About.

We’re an award-winning global specialist healthcare communications consultancy, creators of the Patient Advocacy & Centricity Tracker tool and founders of the global Patient Partnership Index.

The Health Change Makers.

OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.
Site by XYCO

OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.

Site by XYCO